Quantification of keratan sulfate in blood as a marker of cartilage catabolism. - Wikidata - wikimedia - TriplyDB

Quantification of keratan sulfate in blood as a marker of cartilage catabolism.

Quantification of keratan sulfate in blood as a marker of cartilage catabolism.

http://www.wikidata.org/entity/Q42203470

about

Corneal dystrophies Human corneal GlcNac 6-O-sulfotransferase and mouse intestinal GlcNac 6-O-sulfotransferase both produce keratan sulfate Linkage of a gene for macular corneal dystrophy to chromosome 16 Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene Enzymes responsible for synthesis of corneal keratan sulfate glycosaminoglycans Fatty acid composition of adipose tissue and serum micronutrients in relation to common rheumatic complaints in Swedish adults 50-70 years old Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases Effect of longeing and glucosamine supplementation on serum markers of bone and joint metabolism in yearling quarter horses Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.Establishment of glycosaminoglycan assays for mucopolysaccharidoses Cartilage matrix glycoprotein is present in serum in experimental canine osteoarthritis.Shotgun proteomic analysis of plasma from dairy cattle suffering from footrot: characterization of potential disease-associated factors Epitopes of proteoglycans eliciting an anti-proteoglycan response in chronic immune synovitis.Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate.Coexistence of macular corneal dystrophy types I and II in a single sibship.Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees.Effect of Polycalcium, a mixture of Polycan and calcium lactate-gluconate in a 1:9 weight ratio, on rats with surgery-induced osteoarthritis Immunolocalization of proteoglycan types in aortas of pigeons with spontaneous or diet-induced atherosclerosis Comparison of mobility changes with histological and biochemical changes during lipopolysaccharide-induced arthritis in the hamster.The treatment of osteoarthritis.Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment.The potential value of blood biomarkers of intervertebral disk metabolism in the follow-up of patients with sciatica.Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis Markers of cartilage metabolism in arthrosis. A review.Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.Genetic analysis of CHST6 and TGFBI in Turkish patients with corneal dystrophies: Five novel variations in CHST6.Serum keratan sulfate transiently increases in the early stage of osteoarthritis during strenuous running of rats: protective effect of intraarticular hyaluronan injection.Changes in synovial fluid biochemical markers following arthroscopic surgery in patients with knee osteoarthritis.Therapeutic progress--review XXV. Osteoarthritis--are we making progress?Modulation of neonatal growth plate development by ex vivo intermittent mechanical stress.Markers of osteoarthritis: a review of the literature.Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation.Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease Chondroprotective drugs and osteoarthritis.Immunochemical markers of joint inflammation, skeletal damage and repair: where are we now?Studies of a monoclonal antibody to skeletal keratan sulphate. Importance of antibody valency

P2860

Q21093170-246DC9E7-2597-4F94-9793-7D60837CFF3E Q24291020-DA8EA853-3319-494C-B6C0-79420288BBB9 Q24676075-A564CE09-304C-412A-96E9-D09879108776 Q24804396-4C76EB54-27F5-4B4B-A307-7BD9E926ECED Q28140300-16B22EB9-9BC2-4FF2-8C3F-31DF12D090D9 Q28240111-D993357B-8458-4541-B2F9-D87C6E608C95 Q28318858-4923CD7E-97C1-4E2B-B82E-C349BCDB603C Q33584036-9C6C2B5D-132A-4CFB-BA16-E52701CB202E Q33923650-3AF2E836-0879-4B72-AA41-2675BDFD070A Q34087323-762DE34C-9BB1-450F-BC2A-1A70E80D6397 Q34233714-71A388C4-1493-4B25-95E1-3B09D880B04E Q34318230-BA8C35D3-7DEC-4368-9811-ABDB5607D708 Q34578553-17CBADC1-20B0-4482-B5B5-FCA03DEB0A25 Q34589687-236FDA82-08B0-43BA-A0A6-AB59DEFB962A Q34593904-32902B9E-34BA-449F-8302-2118C63840B0 Q34897305-C8B420F0-038C-4E13-B845-7EAF08C005BE Q35304047-8FAEE9EF-9406-4EEF-AF12-F8E54384F5C4 Q35547258-C8457040-5C3D-468A-A82F-C51B2E1FBD6B Q35754340-ABF7B3B9-704B-4BF5-83CF-EBD8BA760930 Q35815981-3998CCCB-4E08-4A0F-9152-E718FE86B159 Q35833890-8FF2FEAC-BFC7-4D1F-AD70-4FC8326077A3 Q36067762-5FC147DD-B987-4CE9-B7EE-8BCEB3EBB688 Q36102860-C07B9D64-BF28-4D73-83CF-29FFF45B3B8D Q36310851-6389BE31-BCD1-4B7D-910F-2A0BFE4FF17D Q36372359-5885CB13-CB91-4343-8F58-9841EA6BAE6D Q36598469-51C5CA5D-5EA8-4586-B342-3409F981E21E Q36901731-D2B80128-F663-4756-8A32-CA1E7EA5EA84 Q37029663-D709AC09-FC1D-4E0E-A4E6-42D43D572454 Q37361470-3EDD9D51-DBCD-40C4-B703-026ADEC24D1C Q37371325-89492A8C-100C-4DDC-9EDE-59B00ACC5700 Q38274507-8FDA07E2-5721-4529-B793-869DCE77823A Q39637379-4279C501-6B12-4825-B670-537EDEDD35DD Q39655751-A18EF527-4D4B-4157-9DA6-AA3980CCFA76 Q39971303-A15FDBA0-67DB-461F-9434-1282F0FF71B9 Q40469962-A1198CDA-ED3A-4AD3-A454-EEC9D9FDEC5B Q40827261-9A8C7047-E216-40AD-99BC-C89FABD1FF30 Q41203773-7040C270-CC68-4ADF-8962-EC06E335EA91 Q41222732-D50EF8FA-759F-4A92-977A-7D1C5CFD2880 Q41269818-8F8F70D5-8D06-491E-8AF6-4F8B873EDB49 Q41820839-6DD7D42B-FB0E-4714-85E9-413A5BE74B05

P2860

Quantification of keratan sulfate in blood as a marker of cartilage catabolism.

http://www.wikidata.org/entity/Q42203470

description

1985 nî lūn-bûn

@nan

1985年の論文

@ja

1985年論文

@yue

1985年論文

@zh-hant

1985年論文

@zh-hk

1985年論文

@zh-mo

1985年論文

@zh-tw

1985年论文

@wuu

1985年论文

@zh

1985年论文

@zh-cn

name

Quantification of keratan sulfate in blood as a marker of cartilage catabolism.

@en

type

label

Quantification of keratan sulfate in blood as a marker of cartilage catabolism.

@en

prefLabel

Quantification of keratan sulfate in blood as a marker of cartilage catabolism.

@en

P1433

Q42203470-C14BDE91-0B29-4749-BD08-0985DFA8FFEE

P1476

Q42203470-7B434127-01FF-4F5E-9C8C-F80B63A57914

P2093

Q42203470-02AC7CA7-14EF-42FD-90D7-B4924009EB52

Q42203470-1EC90A12-6FC6-4AA1-AB5E-C6C502E91DC3

Q42203470-25B5D47C-A06A-4E7D-BC8A-8FA5F699C383

Q42203470-6F1FBDB2-603C-4A46-BC50-13ABB5A49FBB

Q42203470-7E4CBC18-E76A-4225-A601-28F125826107

Q42203470-96DB1C59-C0A1-420F-821A-4FA3C25EC5A9

Q42203470-9FE759DC-CA90-48E9-9D78-6423E91B6E6C

Q42203470-A84F082C-3D86-4146-8A1C-09ACE19A134D

Q42203470-DD8495DF-AE0D-4435-ADA1-1E9F800F3D57

P2860

Q42203470-06FB1D7B-CABE-4EAF-8870-C5B03590730B

Q42203470-1831A7C9-699A-4779-B670-A3CE9A98D47A

Q42203470-22829553-2A76-4DCC-AF22-52BFF3B1769A

Q42203470-9CF6C2AD-72C1-404F-A238-2F03C1F1ABB6

Q42203470-BCDE6B12-7BC1-4933-9893-6332483C6F5E

Q42203470-F807003A-CD50-4801-A883-376AE1343B45

P304

Q42203470-0FA50126-A82F-4B43-89B9-64F363B949D4

P31

Q42203470-A6E526D7-95C8-4E06-967C-6B3935AA193A

P356

Q42203470-0EDC9DE1-A04E-4592-9022-A43A4F2BA289

P433

Q42203470-E856118B-8A9A-4CB9-A8A2-31DCFED62874

P478

Q42203470-94865F22-881A-436D-91D2-4CBC006312EB

P577

Q42203470-97CED301-7809-4F72-8F75-CB5E1F7947A6

P5875

Q42203470-328E7415-19E3-4A58-9278-5027229747C5

P698

Q42203470-4DA1C998-0662-4E36-98B4-641E1B202202

P921

Q42203470-F48464F8-C811-474B-B895-95348B3459E1

P356

P1433

Arthritis & Rheumatology

P1476

Quantification of keratan sulfate in blood as a marker of cartilage catabolism.

@en

P2093

Caterson B

http://www.w3.org/2001/XMLSchema#string

Glickman P

http://www.w3.org/2001/XMLSchema#string

Huff J

http://www.w3.org/2001/XMLSchema#string

Katz R

http://www.w3.org/2001/XMLSchema#string

Klintworth GK

http://www.w3.org/2001/XMLSchema#string

Kuettner KE

http://www.w3.org/2001/XMLSchema#string

Lenz ME

http://www.w3.org/2001/XMLSchema#string

Pachman LM

http://www.w3.org/2001/XMLSchema#string

Thonar EJ

http://www.w3.org/2001/XMLSchema#string

P2860

The glycosaminoglycans of human plasma.

An oligosaccharide component in proteoglycans of articular cartilage.

Degradation of keratan sulphate by beta-N-acetylhexosaminidases A and B.

The excretion and degradation of chondroitin 4-sulphate administered to guinea pigs as free chondroitin sulphate and as proteoglycan.

The degradation of intravenously injected chondroitin 4-sulphate in the rat.

Characterization of the keratan sulphate proteoglycans from bovine corneal stroma.

P304

1367-1376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.1780281209

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

1985-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227861063

http://www.w3.org/2001/XMLSchema#string

P698

2935158

http://www.w3.org/2001/XMLSchema#string

P921